Ganga Pharmaceuticals appoints auditor for FY 2026-27
Ganga Pharmaceuticals Limited has appointed M/s. D Maurya & Associates as its Secretarial Auditor for FY 2026-27 following a Board meeting on May 21, 2026. The firm, led by Mr. Dhirendra Maurya, brings expertise in SEBI LODR compliance and company law advisory.

*this image is generated using AI for illustrative purposes only.
Ganga Pharmaceuticals Limited has appointed M/s. D Maurya & Associates as its Secretarial Auditor for the financial year 2026-27. The decision was approved by the company's Board of Directors during a meeting held on May 21, 2026, based on the recommendation of the Audit Committee.
The appointment was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The firm, led by Mr. Dhirendra Maurya, a Practicing Company Secretary, will oversee the secretarial audit compliance for the company.
Details of the Appointment
The Board Meeting, which commenced at 03:30 p.m. and concluded at 4:00 p.m., sanctioned the appointment. The tenure for the auditor covers the financial year 2026-27. The disclosure regarding this change has been made in accordance with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Profile of the Auditor
M/s. D Maurya & Associates is a Mumbai-based proprietary firm established in 2010. Mr. Dhirendra Maurya, the proprietor, is an Associate Member of the Institute of Company Secretaries of India (ICSI) with Membership No. 22005. He holds a Certificate of Practice No. 9594 and a Peer Review Certificate 2544/2022.
| Particulars | Details |
|---|---|
| Reason for Change | Appointment |
| Date of Appointment | May 21, 2026 |
| Firm | M/s. D Maurya & Associates |
| Proprietor | Mr. Dhirendra Maurya |
| Tenure | Financial Year 2026-27 |
| C.P. No. | 9594 |
| Peer Review Certificate | 2544/2022 |
The company confirmed that there are no relationships to disclose between the directors of Ganga Pharmaceuticals Limited and the newly appointed auditor. The information is available on the company's website.
Historical Stock Returns for Ganga Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | +1.69% | -17.81% | +100.00% |
How might the appointment of a new secretarial auditor impact Ganga Pharmaceuticals' upcoming regulatory compliance disclosures and governance ratings?
What were the findings of the previous secretarial auditor, and could any unresolved compliance issues influence the company's stock performance in FY 2026-27?
Could this governance change signal broader strategic restructuring at Ganga Pharmaceuticals, such as leadership transitions or potential mergers and acquisitions?
































